Bluprynt | $4,250,000 | (Feb 27, 2026)
UpGuard | $75,000,000 | (Feb 27, 2026)
Revel(US) | $150,000,000 | (Feb 27, 2026)
Certified by Founder
Lodge
Xenocor
start up
United States
- Salt Lake City, Utah
- 19/04/2023
- Series A
- $10,000,000
Xenocor is actively solving challenges in minimally invasive surgery by bringing the Saberscope single-use, fog-free, articulating laparoscopic platform to market.
Xenocor is a privately held corporation, based in Salt Lake City, UT. Learn more at: www.saberscope.com/resources
- Industry Medical Equipment Manufacturing
- Website https://xenocor.com/
- LinkedIn https://www.linkedin.com/company/xenocor/
Related People
Charles DeCoster IVFounder
United States -
Washington, Utah
Life Sciences senior leader specializing in Investor Relations, Strategy, Business Development/M&A, Upstream Marketing and Portfolio Management
Alpa | $3,500,000 | (Feb 27, 2026)
ElastixAI | $18,000,000 | (Feb 27, 2026)
Callosum | $10,250,000 | (Feb 27, 2026)
JetScale AI | $5,400,000 | (Feb 27, 2026)
Dots | $8,900,000 | (Feb 27, 2026)
VITURE | $100,000,000 | (Feb 27, 2026)
Ark Climate | $2,478,315 | (Feb 27, 2026)
Jest | $7,000,000 | (Feb 27, 2026)
Sinergy Flow | $8,273,230 | (Feb 26, 2026)